Albemarle Completes Sale of Controlling Stake in Ketjen to KPS Capital Partners

Rhea-AI Summary

Albemarle (NYSE: ALB) completed sale of a controlling stake in Ketjen's refining catalyst solutions business to KPS Capital Partners on March 2, 2026, while retaining a minority stake and full ownership of Ketjen's Performance Catalyst Solutions business, which Albemarle integrated into its portfolio. Combined with a January 2026 sale of a 50% Eurecat interest, Albemarle received $670 million in pre-tax proceeds to be used for debt reduction and general corporate purposes.

Positive

• $670 million combined pre-tax proceeds received
• Retains minority stake in Ketjen
• Keeps 100% ownership of Performance Catalyst Solutions

Negative

• Relinquished controlling stake and operational control of Ketjen refining business
• KPS holds majority board and operational decision authority

Key Figures

Transaction proceeds: $670 million Eurecat stake sold: 50% interest KPS AUM: $19.5 billion +4 more

7 metrics

Transaction proceeds $670 million Combined pre-tax proceeds from Ketjen and Eurecat transactions

Eurecat stake sold 50% interest Interest in Eurecat joint venture sold to Axens SA in Jan 2026

KPS AUM $19.5 billion Assets under management as of September 30, 2025

Portfolio revenue $21.2 billion Aggregate annual revenues of KPS portfolio companies

Manufacturing facilities 202 facilities KPS portfolio companies’ global manufacturing footprint

Countries of operation 21 countries Countries where KPS portfolio companies operate

Employees 55,000 employees Employees across KPS portfolio and joint ventures

Market Reality Check

Price: $178.50 Vol: Volume 1,732,462 is 41% b...

low vol

$178.50 Last Close

Volume Volume 1,732,462 is 41% below 20-day average of 2,952,503, suggesting a relatively subdued reaction. low

Technical Shares at $178.50 are trading 71% above the 200-day MA of $104.38, and 13.35% below the 52-week high.

Peers on Argus

ALB fell 3.39% while key peers like EMN (+1.92%) and NEU (+0.23%) were up, with ...

ALB fell 3.39% while key peers like EMN (+1.92%) and NEU (+0.23%) were up, with AXTA (+0.07%) and ESI (‑0.03%) near flat. Sector moves did not mirror ALB’s decline, pointing to company-specific trading.

Historical Context

5 past events · Latest: Feb 11 (Negative)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 11	Operational capacity move	Negative	-9.4%	Idling Kemerton lithium hydroxide plant trains to improve financial flexibility.
Feb 11	Earnings release	Negative	-9.4%	Q4 2025 net loss driven by tax items and Ketjen write-down despite sales growth.
Jan 13	Earnings date notice	Neutral	+0.4%	Announcement of timing and access details for Q4 2025 earnings release.
Dec 12	Offtake agreement	Positive	-1.4%	Positive offtake and royalty news around cesium concentrate at Case Lake project.
Nov 05	Earnings release	Positive	-0.8%	Q3 2025 showed higher Adjusted EBITDA and strong cash flow despite reported net loss.

Pattern Detected

Recent ALB news often saw negative price reactions even to mixed or operationally positive updates, including earnings and strategic portfolio actions.

Recent Company History

Over the past months, Albemarle has combined portfolio reshaping with operational adjustments. On Nov 5, 2025, Q3 results showed $1.3B net sales and positive cash flow but a net loss and Ketjen impairment. By Dec 12, 2025, a cesium offtake deal linked ALB to Case Lake development. On Feb 11, 2026, Q4 results and a decision to idle parts of the Kemerton lithium hydroxide plant both coincided with a ‑9.41% move. Today’s Ketjen stake sale and $670M proceeds continue that focus on portfolio and cash optimization.

Market Pulse Summary

This announcement details Albemarle’s completed sale of a controlling stake in Ketjen’s refining cat...

Analysis

This announcement details Albemarle’s completed sale of a controlling stake in Ketjen’s refining catalyst business and the earlier sale of its 50% Eurecat interest, yielding combined pre-tax proceeds of $670 million targeted for debt reduction and general corporate uses. Historically, Albemarle’s news flow has mixed portfolio actions, plant idling and earnings volatility. Investors may monitor how these proceeds affect leverage, future earnings reports, and any further shifts in the company’s asset base.

Key Terms

forward-looking statements, form 10-k, form 10-q

3 terms

forward-looking statements regulatory

"This press release contains statements concerning our expectations... which constitute "forward-looking statements""

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

form 10-k regulatory

"those described under "Risk Factors" in Albemarle's most recent Annual Report on Form 10-K"

A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.

form 10-q regulatory

"and any subsequently filed Quarterly Reports on Form 10-Q, which are filed with the SEC"

A Form 10-Q is a detailed report that publicly traded companies are required to file with regulators three times a year, providing an update on their financial health and business activities. It is important for investors because it offers timely insights into a company's performance, helping them make informed decisions about buying or selling stocks. Think of it as a regular check-up report that shows how well a company is doing.

AI-generated analysis. Not financial advice.

CHARLOTTE, N.C., March 2, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity, and health, today announced it has completed the sale of a controlling stake in Ketjen Corporation's refining catalyst solutions business (Ketjen) to affiliates of KPS Capital Partners, LP (KPS).

Albemarle retains a minority stake in Ketjen, with KPS having a majority of the Board of Directors and operational control. Albemarle retains 100% ownership of Ketjen's Performance Catalyst Solutions business, which has been integrated into Albemarle's product portfolio.

Combined with the sale of its 50% interest in the Eurecat joint venture to Axens SA, which was completed in January 2026, Albemarle has received a combined $670 million in pre-tax proceeds between the two transactions. Albemarle expects to use the proceeds for debt reduction and other general corporate purposes.

"Our continued investment in Ketjen alongside KPS demonstrates our confidence in the company's growth and value-creation potential," said Kent Masters, Chairman and CEO of Albemarle. "We are committed to supporting Ketjen's next chapter while strengthening Albemarle's portfolio focus and financial flexibility."

Goldman Sachs & Co. LLC acted as exclusive financial advisor, and K&L Gates LLP served as legal advisor to Albemarle for the transaction.

About Albemarle 
Albemarle Corporation (NYSE: ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect with people and planet in mind. A reliable and high-quality global supply of lithium and bromine allows us to deliver advanced solutions for our customers. Learn more about how the people of Albemarle are enabling a more resilient world at Albemarle.com.

Albemarle regularly posts information to Albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, U.S. Securities and Exchange Commission filings and other information regarding the company, its businesses and the markets it serves. 

About KPS Capital Partners
KPS, through its affiliated management entities, is the manager of the KPS Special Situations Funds, a family of investment funds with approximately $19.5 billion of assets under management (as of September 30, 2025). For over three decades, the Partners of KPS have worked exclusively to realize significant capital appreciation by making controlling equity investments in manufacturing and industrial companies across a diverse array of industries, including basic materials, branded consumer, healthcare and luxury products, automotive parts, capital equipment and general manufacturing. KPS creates value for its investors by working constructively with talented management teams to make businesses better, and generates investment returns by structurally improving the strategic position, competitiveness and profitability of its portfolio companies, rather than primarily relying on financial leverage. The KPS Funds' portfolio companies currently generate aggregate annual revenues of approximately $21.2 billion, operate 202 manufacturing facilities in 21 countries, and have approximately 55,000 employees, directly and through joint ventures worldwide (as of September 30, 2025). The KPS investment strategy and portfolio companies are described in detail at www.kpsfund.com.

Forward-Looking Statements
This press release contains statements concerning our expectations, anticipations and beliefs regarding the future, which constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties, often contain words such as "ambition" "anticipate," "believe," "estimate," "expect," "goals" "guidance," "intend," "may," "outlook," "scenario," "should," "would," and "will" and similar references to future periods. Forward-looking statements may include statements regarding: plans and expectations regarding use of transaction proceeds, financial flexibility and optionality, future investments and support, value-creation potential, portfolio focus, other underlying assumptions and outlook considerations, and all other information relating to matters that are not historical facts. These and other forward-looking statements are based on management's current estimates, assumptions and expectations and involve risks and uncertainties that could significantly affect expected results. Actual results could differ materially from those expressed or implied in the forward-looking statements if one or more of the underlying estimates, assumptions or expectations prove to be inaccurate or are unrealized. Factors that could cause Albemarle's actual results to differ materially from the outlook expressed or implied in any forward-looking statement include: breaches of contract; changes in economic and business conditions; changes in trade policies and tariffs; technological change and development; completion of the audit of our annual financial statements; fluctuations in foreign currencies; changes in laws and government regulation; regulatory actions, proceedings, claims or litigation; cyber-security breaches, terrorist attacks, industrial accidents or natural disasters; geopolitical conflicts and political unrest; trade policies and tariffs; changes in inflation or interest rates; volatility in the debt and equity markets; acquisition and divestiture transactions; timing and success of projects; changes in credit ratings; and the other factors detailed from time to time in the reports Albemarle files with the SEC, including those described under "Risk Factors" in Albemarle's most recent Annual Report on Form 10-K and any subsequently filed Quarterly Reports on Form 10-Q, which are filed with the SEC and available on the investor section of Albemarle's website (investors.albemarle.com) and on the SEC's website at www.sec.gov. These forward-looking statements speak only as of the date of this press release. Albemarle assumes no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

Investor Relations Contact: +1 (980) 308-6194, invest@albemarle.com 
Media Contact: Ryan Dean, +1 (980) 308-6310, media@albemarle.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/albemarle-completes-sale-of-controlling-stake-in-ketjen-to-kps-capital-partners-302701526.html

SOURCE Albemarle Corporation

FAQ

What did Albemarle (ALB) announce about Ketjen on March 2, 2026?

Albemarle completed sale of a controlling stake in Ketjen's refining catalyst solutions business. According to the company, Albemarle retains a minority stake and kept 100% ownership of Ketjen's Performance Catalyst Solutions business integrated into its portfolio.

How much did Albemarle (ALB) receive from the Ketjen and Eurecat transactions?

Albemarle received $670 million in combined pre-tax proceeds from the two transactions. According to the company, proceeds come from the Ketjen controlling-stake sale and the January 2026 Eurecat 50% interest sale, to be used for debt reduction and general purposes.

What control changes resulted from Albemarle's sale of Ketjen stake to KPS?

KPS now holds majority of Ketjen's board and operational control of the refining catalyst business. According to the company, Albemarle retains only a minority stake and no operational control over that business segment.

Will Albemarle (ALB) continue to operate Ketjen's Performance Catalyst Solutions?

Yes, Albemarle retains 100% ownership of Ketjen's Performance Catalyst Solutions business. According to the company, that business has been integrated into Albemarle's product portfolio and remains under Albemarle control.

How does Albemarle (ALB) plan to use the proceeds from the Ketjen transaction?

Albemarle intends to use the proceeds for debt reduction and other general corporate purposes. According to the company, the combined $670 million in pre-tax proceeds will strengthen financial flexibility and support portfolio focus.